rs1060502085
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_003072.5(SMARCA4):c.662delC(p.Pro221fs) variant causes a frameshift change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: not found (cov: 32)
Consequence
SMARCA4
NM_003072.5 frameshift
NM_003072.5 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 5.54
Genes affected
SMARCA4 (HGNC:11100): (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4) The protein encoded by this gene is a member of the SWI/SNF family of proteins and is similar to the brahma protein of Drosophila. Members of this family have helicase and ATPase activities and are thought to regulate transcription of certain genes by altering the chromatin structure around those genes. The encoded protein is part of the large ATP-dependent chromatin remodeling complex SNF/SWI, which is required for transcriptional activation of genes normally repressed by chromatin. In addition, this protein can bind BRCA1, as well as regulate the expression of the tumorigenic protein CD44. Mutations in this gene cause rhabdoid tumor predisposition syndrome type 2. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 12 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 19-10986493-AC-A is Pathogenic according to our data. Variant chr19-10986493-AC-A is described in ClinVar as [Pathogenic]. Clinvar id is 408653.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SMARCA4 | NM_001387283.1 | c.662delC | p.Pro221fs | frameshift_variant | 4/36 | ENST00000646693.2 | NP_001374212.1 | |
SMARCA4 | NM_003072.5 | c.662delC | p.Pro221fs | frameshift_variant | 4/35 | ENST00000344626.10 | NP_003063.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SMARCA4 | ENST00000646693.2 | c.662delC | p.Pro221fs | frameshift_variant | 4/36 | NM_001387283.1 | ENSP00000495368.1 | |||
SMARCA4 | ENST00000344626.10 | c.662delC | p.Pro221fs | frameshift_variant | 4/35 | 1 | NM_003072.5 | ENSP00000343896.4 | ||
SMARCA4 | ENST00000643549.1 | c.662delC | p.Pro221fs | frameshift_variant | 4/35 | ENSP00000493975.1 | ||||
SMARCA4 | ENST00000541122.6 | c.662delC | p.Pro221fs | frameshift_variant | 5/35 | 5 | ENSP00000445036.2 | |||
SMARCA4 | ENST00000643296.1 | c.662delC | p.Pro221fs | frameshift_variant | 4/34 | ENSP00000496635.1 | ||||
SMARCA4 | ENST00000644737.1 | c.662delC | p.Pro221fs | frameshift_variant | 4/34 | ENSP00000495548.1 | ||||
SMARCA4 | ENST00000589677.5 | c.662delC | p.Pro221fs | frameshift_variant | 5/35 | 5 | ENSP00000464778.1 | |||
SMARCA4 | ENST00000643995.1 | c.74delC | p.Pro25fs | frameshift_variant | 1/32 | ENSP00000496004.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome Cov.: 34
GnomAD4 exome
Cov.:
34
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Rhabdoid tumor predisposition syndrome 2 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 21, 2016 | This sequence change deletes 1 nucleotide in exon 4 of the SMARCA4 mRNA (c.662delC), causing a frameshift at codon 221. This creates a premature translational stop signal (p.Pro221Leufs*82) and is expected to result in an absent or disrupted protein product. While this particular variant has not been reported in the literature, loss-of-function variants in SMARCA4 are known to be pathogenic (PMID: 24658001, 24658002). For these reasons, this variant has been classified as Pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at